1. Pink Sheet
  2. >>Geography
  3. >>Asia
  4. >>South Korea

Deals Of The Week Wonders: What Does Merck’s Latest Biosimilar Move Really Mean?

 
• By Jessica Merrill, Sten Stovall, Lisa LaMotta, Michael Goodman, and Stacy Lawrence

Plus a look at Roche/Chiasma, Chiesi/Cornerstone, Eisai/Valeant and more

Ever since Merck & Co. jumped into the biosimilar field in 2008 with a ferocious go get ’em attitude more fitting of a National Football League tackle than a big pharma, we’ve been following their progress – and then lack of progress – closely. Back when most pharmaceutical manufacturers were still griping about defending their biologic brands, Merck’s early aggressive ambitions made an interesting case study in how a big pharma might strike offensively by positioning itself as a contender in the biosimilar space.

So the company’s announcement Feb. 20 that it has partnered with Korea’s Samsung BioepsisCo. Ltd. to develop multiple undisclosed biosimilar...

More from South Korea

New Era Begins In Korea: Policy Predictions For Biopharma

 
• By Jung Won Shin

As South Korea's new president immediately gets to work on setting initial policies, essential drug supplies, R&D incentives and AI-driven digital healthcare are among the key topics in focus.

Korean Pharma Industry Proposes Policies As Election Nears

 
• By Jung Won Shin

As South Korea gears up for a snap presidential election, its biopharma industry proposes key desired policies to candidates, most of whom have not laid out detailed plans of their own for the sector.

DIA Korea: Medical Turmoil, Global Factors Blunt Korea’s Trial Edge

 
• By Jung Won Shin

DIA Korea hears how multiple domestic and global factors are affecting the environment for clinical trials in South Korea, and what actions may be taken to address this.

US Tariff Impact On Korea Dissected As Country Gears For Presidential Election

 
• By Jung Won Shin

Analysts expect a limited impact on South Korean pharma from US tariffs, even if imposed at a later date. Meanwhile, the early June domestic presidential election is set to determine the direction of policies in the sector.

More from Asia